Physician profile
Abhinav Sharma
NPI 1518298280
$7,361.30
in general payments reported to CMS, 2019-2025
18 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $26.21 · 2021: $225 · 2022: $6,035 · 2023: $89.78 · 2024: $32.80 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787 · Travel and Lodging: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.98 |
| Travel and Lodging | $157.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $6,256.68 | 2021-2025 | Camzyos |
| Heartflow, INC. | $337.65 | 2025 | |
| Orthofix Medical, INC. | $157.93 | 2025 | Mariner Deformity |
| Neo Spine USA, INC. | $139.96 | 2025 | Neo Pedicle Screw System |
| Astrazeneca Pharmaceuticals LP | $129.80 | 2019 | |
| Medtronic, INC. | $82.72 | 2021 | |
| Novartis Pharmaceuticals Corporation | $32.80 | 2024 | |
| Siemens Medical Solutions USA, INC. | $27.50 | 2025 | Biograph Horizon-3r |
| Ge Healthcare | $26.21 | 2020 | |
| Abbott Laboratories | $24.01 | 2025 | Cardiomems |
| Alnylam Pharmaceuticals INC. | $22.34 | 2025 | Amvuttra |
| Altathera Pharmaceuticals LLC | $20.85 | 2025 | Sotalol Hydrochloride |
| Regeneron Healthcare Solutions, INC. | $19.22 | 2025 | Evkeeza |
| Microtransponder, INC. | $18.94 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.45 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.96 | 2025 | Repatha |
| Boston Scientific Corporation | $16.65 | 2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.